Loading...

Chin, Arnold I

Title(s)Associate Professor, Urology
Phone68183
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wang L, Smith BA, Balanis NG, Tsai BL, Nguyen K, Cheng MW, Obusan MB, Esedebe FN, Patel SJ, Zhang H, Clark PM, Sisk AE, Said JW, Huang J, Graeber TG, Witte ON, Chin AI, Park JW. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes. Proc Natl Acad Sci U S A. 2020 01 07; 117(1):563-572. PMID: 31871155.
      View in: PubMed
    2. Hu J, Ishihara M, Chin AI, Wu L. Establishment of xenografts of urological cancers on chicken chorioallantoic membrane (CAM) to study metastasis. Precis Clin Med. 2019 Sep; 2(3):140-151. PMID: 31598385.
      View in: PubMed
    3. Prado K, Zhang KX, Pellegrini M, Chin AI. Sequencing of cancer cell subpopulations identifies micrometastases in a bladder cancer patient. Oncotarget. 2017 Jul 11; 8(28):45619-45625. PMID: 28487492.
      View in: PubMed
    4. Prado K, Chin AI. How nerve-sparing technique has been applied to radiotherapy? Asian J Androl. 2016 Nov-Dec; 18(6):898-899. PMID: 27453071.
      View in: PubMed
    5. Zhang H, Prado K, Zhang KX, Peek EM, Lee J, Wang X, Huang J, Li G, Pellegrini M, Chin AI. Biased Expression of the FOXP3?3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance. Clin Cancer Res. 2016 Nov 01; 22(21):5349-5361. PMID: 27189164.
      View in: PubMed
    6. Eggener SE, Badani K, Barocas DA, Barrisford GW, Cheng JS, Chin AI, Corcoran A, Epstein JI, George AK, Gupta GN, Hayn MH, Kauffman EC, Lane B, Liss MA, Mirza M, Morgan TM, Moses K, Nepple KG, Preston MA, Rais-Bahrami S, Resnick MJ, Siddiqui MM, Silberstein J, Singer EA, Sonn GA, Sprenkle P, Stratton KL, Taylor J, Tomaszewski J, Tollefson M, Vickers A, White WM, Lowrance WT. Gleason 6 Prostate Cancer: Translating Biology into Population Health. J Urol. 2015 Sep; 194(3):626-34. PMID: 25849602.
      View in: PubMed
    7. Li DR, Zhang H, Peek E, Wang S, Du L, Li G, Chin AI. Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer. J Urol. 2015 Aug; 194(2):547-55. PMID: 25748177.
      View in: PubMed
    8. Peek EM, Song W, Zhang H, Huang J, Chin AI. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes. Prostate. 2015 Apr 01; 75(5):463-73. PMID: 25597486.
      View in: PubMed
    9. Wang JG, Huang J, Chin AI. RARP in high-risk prostate cancer: use of multi-parametric MRI and nerve sparing techniques. Asian J Androl. 2014 Sep-Oct; 16(5):715-9. PMID: 24969055.
      View in: PubMed
    10. Zhang H, Chin AI. Role of Rip2 in development of tumor-infiltrating MDSCs and bladder cancer metastasis. PLoS One. 2014; 9(4):e94793. PMID: 24733360.
      View in: PubMed
    11. Evers PD, Logan JE, Sills V, Chin AI. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma. World J Urol. 2014 Apr; 32(2):385-91. PMID: 23756991.
      View in: PubMed
    12. Peek EM, Li DR, Zhang H, Kim HP, Zhang B, Garraway IP, Chin AI. Stromal modulation of bladder cancer-initiating cells in a subcutaneous tumor model. Am J Cancer Res. 2012; 2(6):745-51. PMID: 23226620.
      View in: PubMed
    13. Kaplan AL, Margolis DJ, Said J, Chin AI. Primary carcinoid tumor of urinary bladder discovered on pelvic magnetic resonance imaging. Urology. 2012 Nov; 80(5):e55-7. PMID: 23107414.
      View in: PubMed
    14. Finley DS, Pouliot F, Shuch B, Chin A, Pantuck A, Dekernion JB, Belldegrun AS. Ultrasound-based combination therapy: potential in urologic cancer. Expert Rev Anticancer Ther. 2011 Jan; 11(1):107-13. PMID: 21166515.
      View in: PubMed
    15. Finley DS, Pouliot F, Chin AI, Shuch B, Pantuck AJ, Belldegrun AS, Dekernion JB. Immunological therapy in urological malignancy: novel combination strategies. Int J Urol. 2011 Feb; 18(2):94-101. PMID: 21073543.
      View in: PubMed
    16. Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, Dempsey PW, Cheng G. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer Res. 2010 Apr 01; 70(7):2595-603. PMID: 20233880.
      View in: PubMed
    17. Chin AI, Rutman M, Raz S. Transverse vaginal septum with congenital vesical-vaginal communication and cyclical hematuria. Urology. 2007 Mar; 69(3):575.e5-7. PMID: 17382175.
      View in: PubMed
    18. Chin AI, Dave DS, Rajfer J. Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary? Rev Urol. 2007; 9(3):124-31. PMID: 17934569.
      View in: PubMed
    19. Chin AI, Lam JS, Figlin RA, Belldegrun AS. Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006; 8(1):1-7. PMID: 16985554.
      View in: PubMed
    20. Chin Ai, Ragavendra N, Hilborne L, Gritsch HA. Fibrin sealant sclerotherapy for treatment of lymphoceles following renal transplantation. J Urol. 2003 Aug; 170(2 Pt 1):380-3. PMID: 12853780.
      View in: PubMed
    21. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 2002 Mar 14; 416(6877):190-4. PMID: 11894097.
      View in: PubMed